Loading...

Major Indexes

Financial Statements

PDS Biotechnology Corporation

PDS Biotechnology Corporation (PDSB)

$2.02
0.03 (+1.51%)

Income Statement

Quarter data
Download PDSB income statement Download PDSB income statement Download PDSB income statement
Year 2019 2018 2017 2016
Earnings Per Share Diluted -1.34-1.67-1.311.44
Net Profit Margin ----
Weighted Average Shares Outstanding 3.753.753.7510.31
Revenue ----
Weighted Average Shares Outstanding (Diluted) 28.8630.3931.244.87
Gross Profit ----
Dividend per Share ----
Operating Income -39.51-51.97-43.10-21.03
Gross Margin ----
Income Tax Expense -1.85-2.59-2.780.38
EBIT Margin ----
Net Income -38.82-50.86-40.87-7.00
Cost of Revenue ----
Earnings Before Tax Margin ----
EBIT -39.51-51.97-43.10-21.03
EBITDA -39.25-51.64-42.80-20.94
Profit Margin ----
Operating Expenses 39.5151.9743.1021.03
Earnings Per Share Basic -1.34-1.67-1.311.44
Earnings before Tax -40.67-53.45-43.65-7.38
Interest Expense 1.202.181.430.03

Balance Sheet Statement

Quarter data
Download PDSB balance shet statement Download PDSB balance sheet statement Download PDSB balance sheet statement
Year 2019 2018 2017 2016
Short-term debt -3.08--
Other Assets ----
Total current liabilities 6.6812.876.382.79
Cash and cash equivalents 106.4088.0734.6512.16
Long-term debt 14.9517.38--
Cash and short-term investments 106.4088.0734.6512.16
Total debt 14.9520.46--
Inventories ----
Deferred revenue ----
Goodwill and Intangible Assets ----
Total non-current liabilities 14.9517.38--
Total non-current assets 3.563.570.570.02
Total liabilities 21.6430.256.382.79
Total assets 110.9192.6236.2214.49
Other comprehensive income 190.34214.31222.6440.63
Short-term investments ----
Property, Plant & Equipment Net 3.423.420.430.02
Net Debt -91.45-67.61-34.65-12.16
Investments ----
Total shareholders equity 89.2862.3729.8411.70
Retained earnings (deficit) -101.07-151.95-192.82-28.94
Long-term investments ----
Receivables ----
Payables 3.474.370.401.20
Total current assets 107.3589.0535.6514.47

Cash Flow Statement

Quarter data
Download PDSB cash flow statement Download PDSB cash flow statement Download PDSB cash flow statement
Year 2019 2018 2017 2016
Investing Cash Flow -0.69-0.19-29.38
Free Cash Flow -32.88-40.89-33.15-18.07
Depreciation & Amortization 0.270.320.300.10
Net cash flow / Change in cash -23.79-18.33-53.4212.16
Effect of forex changes on cash ----
Financing Cash Flow 9.0822.55-20.270.75
Dividend payments ----
Stock-based compensation 5.316.187.473.14
Investment purchases ----
Acquisitions and disposals ----
Capital Expenditure 0.690.19--
Operating Cash Flow -32.19-40.70-33.15-18.07

Retained Earning Schedule

Year 2016 2017 2018 2019
Retained Earnings (Previous Year) -62-101-152-193
Net Income -39-51-41-7
Stock Dividends --0-171
Dividend Paid ----
Retained Earnings -101-152-193-29

PPE Schedule

Year 2016 2017 2018 2019
Gross PPE 3330
Annual Depreciation -0-0-3-0
Capital Expenditure 10--
Net PPE 3300

Intangible and Goodwill Schedule

Year 2016 2017 2018 2019
Intangible and Goodwill (Previous Year) ----
New Purchases ----
Intangible and Goodwill ----

PDS Biotechnology Corporation income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes PDS Biotechnology Corporation FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.